Therapy News and Research

RSS

Estrogen therapy can reverse progression of pulmonary hypertension

UCLA researchers have found that the hormone estrogen may help reverse advanced pulmonary hypertension, a rare and serious condition that affects 2 to 3 million individuals in the U.S., mostly women, and can lead to heart failure.

16 Sep 2011

U.S. HIV/AIDS policy and funding should be guided by science, policy statement recommends

The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.

16 Sep 2011

Positive thoughts improve mental health in men with testicular cancer

Men who channeled positive thoughts into a five-week writing assignment about their testicular cancer showed signs of improved mental health afterward, in contrast to men who wrote negatively or neutrally about their condition, according to results of a Baylor University pilot study.

16 Sep 2011

TCT to showcase major scientific research breakthroughs in cardiovascular medicine

The Cardiovascular Research Foundation has announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2011 scientific symposium. Presented in partnership with the American College of Cardiology (ACC), TCT 2011 is the world's leading educational meeting specializing in interventional cardiovascular medicine and will take place November 7-11, 2011 in San Francisco.

16 Sep 2011

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Treatment with a telaprevir-based combination regimen for hepatitis C - heretofore a chronic, destructive and difficult to manage disease - effectively can be shortened to six months in about two-thirds of patients, finds a new study published Thursday in the New England Journal of Medicine.

16 Sep 2011

Scientists discover new type of spinal cord stem cell

A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis.

16 Sep 2011

St. Jude Medical to again participate in Asia-Pacific Heart Rhythm Society Scientific Session

St. Jude Medical, Inc., a global medical device company, is pleased to again participate in the Asia-Pacific Heart Rhythm Society Scientific Session (APHRS), which is being held this year in conjunction with the Japanese Heart Rhythm Society (JHRS) and the Japanese Society of Electrocardiology (JSE) in Fukuoka, Japan.

16 Sep 2011

U of C researchers create new model of obsessive-compulsive disorder

A new model of obsessive-compulsive disorder (OCD) that mirrors both symptoms of the disease and the timing of its treatment in humans has been created by University of Chicago researchers, according to a new study.

16 Sep 2011

Scientists uncover unknown fail-safe pathway for inherited disorders

Scientists at the University of California, San Diego School of Medicine have uncovered a previously unknown fail-safe (compensatory) pathway that potentially protects the brain and other organs from genetic and environmental threats.

16 Sep 2011

Azithromycin gel may treat borreliosis in humans

Blood-sucking ticks are not just a nuisance, they can also transmit dangerous diseases. One of them is Lyme disease, which is caused by bacteria of the genus Borrelia, and requires a course of treatment with antibiotics lasting several weeks. LMU researchers have come up with a quicker alternative.

16 Sep 2011

New GE healthymagination initiative aims to improve cancer innovation and care

GE and leading healthcare and financial partners today launched a new healthymagination initiative aimed at accelerating cancer innovation and improving care for 10 million cancer patients around the world by 2020.

16 Sep 2011

Polyplus-transfection appoints ten additional biologists and chemists to support multiple pre-clinical studies

Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, today celebrates ten years of continuous growth.

15 Sep 2011

CRF announces late breaking trials & first report investigations to be presented at TCT 2011

The Cardiovascular Research Foundation has announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2011 scientific symposium. Presented in partnership with the American College of Cardiology (ACC), TCT 2011 is the world’s leading educational meeting specializing in interventional cardiovascular medicine and will take place November 7-11, 2011 in San Francisco.

15 Sep 2011

Hypnosis to tackle problems of chronic pain: International expert

A visiting international rehabilitation expert has called for Hypnotic Therapy to be considered a ‘mainstream’ treatment option in the management of chronic pain, potentially benefiting thousands of Australian pain sufferers.

15 Sep 2011

Positive results from PROLOR Biotech's Factor VIIa-CTP preclinical study on hemophilia

PROLOR Biotech, Inc.,, today reported positive results from a comparative study of its biobetter longer-acting version of the hemophilia drug Factor VIIa (Factor VIIa-CTP) in hemophilic mice.

15 Sep 2011

CHK Nutrition, NeuroResearch Clinics sign consent to halt sale of unapproved amino-acid products

The U.S. Food and Drug Administration announced that two Minnesota companies have agreed to halt distribution of amino-acid products marketed to treat a number of diseases, until requirements of the Federal Food, Drug, and Cosmetic Act are met.

15 Sep 2011

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.

15 Sep 2011

NCCN 6th annual congress discusses role of maintenance therapies in follicular lymphoma

While therapeutic advances have improved survival of patients with follicular lymphoma (FL), it remains an incurable disease with inevitable relapse. This underscores the need for therapies and strategies to extend the duration of remission without significantly increasing toxicity and while maintaining quality of life.

15 Sep 2011

Differences in lifestyle, tumor genetics linked to head and neck cancer in African Americans

Why are African Americans more likely than Caucasians to be not only diagnosed with head and neck cancer, but also die from the disease? While the answer isn't a simple one, differences in lifestyle, access to care and tumor genetics may, in part, be to blame, according to a new study from Henry Ford Hospital.

15 Sep 2011

Consensus panel calls for specialized nutrition therapy to manage obesity

A newly published consensus report prepared by a panel of clinical experts, with sponsorship from Nestle Health Science, reveals that there are opportunities to do more to manage the impact of obesity on the delivery of critical care, particularly in the area of nutrition therapy.

15 Sep 2011

Therapy News and Research

Estrogen therapy can reverse progression of pulmonary hypertension

U.S. HIV/AIDS policy and funding should be guided by science, policy statement recommends

Positive thoughts improve mental health in men with testicular cancer

TCT to showcase major scientific research breakthroughs in cardiovascular medicine

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Scientists discover new type of spinal cord stem cell

St. Jude Medical to again participate in Asia-Pacific Heart Rhythm Society Scientific Session

U of C researchers create new model of obsessive-compulsive disorder

Scientists uncover unknown fail-safe pathway for inherited disorders

Azithromycin gel may treat borreliosis in humans

New GE healthymagination initiative aims to improve cancer innovation and care

Polyplus-transfection appoints ten additional biologists and chemists to support multiple pre-clinical studies

CRF announces late breaking trials & first report investigations to be presented at TCT 2011

Hypnosis to tackle problems of chronic pain: International expert

Positive results from PROLOR Biotech's Factor VIIa-CTP preclinical study on hemophilia

CHK Nutrition, NeuroResearch Clinics sign consent to halt sale of unapproved amino-acid products

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

NCCN 6th annual congress discusses role of maintenance therapies in follicular lymphoma

Differences in lifestyle, tumor genetics linked to head and neck cancer in African Americans

Consensus panel calls for specialized nutrition therapy to manage obesity

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News